IHSN Survey Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / NGA_2014_MCBPIE-EL_V01_M / variable [F6]
central

Impact Evaluation of the Use of Community Volunteers and Patent Medicine Vendors for Malaria Control in Anambra State and Gombe State 2014 -2015, Endline Survey

Nigeria, 2014 - 2015
Get Microdata
Reference ID
NGA_2014_MCBPIE-EL_v01_M
Producer(s)
Pedro Carneiro, Edit V. Velenyi
Metadata
DDI/XML JSON
Created on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
109787
Downloads
679
  • Study Description
  • Data Dictionary
  • Downloads
  • Get Microdata
  • Data files
  • cdd_release
  • community_release
  • household_release
  • phf_release
  • phfw_release
  • pmv_release

BRAND NAME, INCLUDING DRUG SPECIFICATIONS (brandname_drug6)

Data file: pmv_release

Overview

Valid: 61
Invalid: 0
Type: Discrete
Start: 5460
End: 5504
Width: 45
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
ACT 1
1.6%
ANATE(amodiaquine+artesunate) 1
1.6%
Amalar 1
1.6%
Amalar ( sp ) 3
4.9%
Amalar(SP) 1
1.6%
Amatem Forte ( Artemether and Lumefantrine ) 1
1.6%
Artemef (ACT ) 1
1.6%
Artemether Lumefantrine 1
1.6%
Artemether and Lumefantrine ( Act ) 2
3.3%
Artemether and Lumefantrine (Act ) 1
1.6%
Artemether lumefantrine (ACT) 1
1.6%
Artequin ( Artesunate ) 1
1.6%
Artequin (Artesunate and mefloquine) 1
1.6%
Artesunat 1
1.6%
Artesunat ( Artesunate ) 1
1.6%
Artesunat (SP) 1
1.6%
Artesunat GMP 1
1.6%
Artesunate 1
1.6%
Artesunate GMP 1
1.6%
Artesunate c.p.50mg ( Artesunate ) 1
1.6%
Atmal-Plus (Artemether and Lumefantrine ) 1
1.6%
Camosunate ACT 1
1.6%
Coartem ACT:-) 1
1.6%
Combisunate (ACT) 1
1.6%
Fralomin 1
1.6%
GRUTHA FORT 1
1.6%
Halfan 2x3 1
1.6%
Koyodrine(proguanil tablets B.P) 1
1.6%
Laridox (SP) 1
1.6%
Laridox (sp ) 1
1.6%
Laridox(S.P) 1
1.6%
Laridox(sp) 1
1.6%
Lifloxin(sp) 1
1.6%
Lonart ACT 1
1.6%
Lonart-DS 1
1.6%
Lonart-DS ( Artemether and Lumefantrine ) 1
1.6%
Malareich 1
1.6%
Malareich (sp ) 1
1.6%
Malareich SP 1
1.6%
Maldox 1
1.6%
Maldox ( sp ) 2
3.3%
Maldox Sp 1
1.6%
Maldox(S.P) 1
1.6%
Maldox(sp) 1
1.6%
Md-artesunate 1
1.6%
Melofan (sp ) 2
3.3%
Metaquine 1
1.6%
Ouimal (chloroquine phosphate) 1
1.6%
P-Alaxin ( Dihydroartemisin and piperaquine ) 1
1.6%
P-alaxin dihydroartemisinin+piperaquine 1
1.6%
Swidar ( sp ) 1
1.6%
V-Martem ( Artemether and Lumefantrine ) 1
1.6%
Waipa ( ACT ) 1
1.6%
Waipa (ACT ) 1
1.6%
Waipa (Act) 1
1.6%
Waipa(act) 1
1.6%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
IHSN Survey Catalog

© IHSN Survey Catalog, All Rights Reserved.